Conning Inc. boosted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 6.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 37,679 shares of the healthcare conglomerate’s stock after acquiring an additional 2,190 shares during the quarter. Conning Inc.’s holdings in UnitedHealth Group were worth $8,307,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of UNH. KBC Group NV boosted its holdings in shares of UnitedHealth Group by 4.7% during the third quarter. KBC Group NV now owns 323,799 shares of the healthcare conglomerate’s stock worth $63,416,000 after purchasing an additional 14,672 shares during the last quarter. DekaBank Deutsche Girozentrale boosted its holdings in shares of UnitedHealth Group by 2.0% during the third quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock worth $95,646,000 after purchasing an additional 9,810 shares during the last quarter. Bainco International Investors boosted its holdings in shares of UnitedHealth Group by 5.4% during the third quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock worth $16,192,000 after purchasing an additional 4,202 shares during the last quarter. Toronto Dominion Bank boosted its holdings in UnitedHealth Group by 69.1% in the third quarter. Toronto Dominion Bank now owns 383,943 shares of the healthcare conglomerate’s stock valued at $75,193,000 after acquiring an additional 156,892 shares during the last quarter. Finally, Norinchukin Bank The boosted its holdings in UnitedHealth Group by 2.7% in the third quarter. Norinchukin Bank The now owns 180,773 shares of the healthcare conglomerate’s stock valued at $35,405,000 after acquiring an additional 4,838 shares during the last quarter. 86.83% of the stock is owned by institutional investors.
UnitedHealth Group Inc (NYSE UNH) traded down $1.41 during midday trading on Wednesday, hitting $225.53. The company’s stock had a trading volume of 2,121,821 shares, compared to its average volume of 3,855,999. The company has a market capitalization of $219,890.00, a PE ratio of 23.77, a P/E/G ratio of 1.30 and a beta of 0.74. UnitedHealth Group Inc has a 52 week low of $162.74 and a 52 week high of $250.79. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.73.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the previous year, the business earned $2.11 EPS. The company’s revenue was up 9.5% on a year-over-year basis. sell-side analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.33%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.58%.
In other news, Director Richard T. Burke sold 10,400 shares of the business’s stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $229.87, for a total transaction of $2,390,648.00. Following the transaction, the director now directly owns 1,781,657 shares in the company, valued at approximately $409,549,494.59. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 53,196 shares of company stock worth $12,291,179. 0.89% of the stock is currently owned by corporate insiders.
A number of research analysts recently weighed in on UNH shares. Cantor Fitzgerald reiterated a “buy” rating and issued a $225.00 target price on shares of UnitedHealth Group in a report on Monday, November 27th. Jefferies Group reissued a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Deutsche Bank raised their price objective on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Royal Bank of Canada raised their price objective on UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Finally, Oppenheimer lifted their target price on UnitedHealth Group from $215.00 to $225.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 29th. Two investment analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $245.14.
TRADEMARK VIOLATION NOTICE: “Conning Inc. Acquires 2,190 Shares of UnitedHealth Group Inc (UNH)” was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://ledgergazette.com/2018/03/14/unitedhealth-group-inc-unh-stake-increased-by-conning-inc.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.